EAST END GROUP, LLC — Lobbying Firm

Filings

839

Clients

Total income

$33,253,000

Lobbyists

Years active

2010–2026

Filings counts every document on the register, amendments included. Income is the fees reported to clients, counting the current version of each report once.

Income by year

Fees reported, $ millions 2010 to 2026

Filings

839 filings, newest first.

Filing	Client	Income	Expenses
3rd Quarter - Amendment 3rd Quarter 2026	PARTNER THERAPUTICS	$40,000 income	— expenses
3rd Quarter - Reportreplaced 3rd Quarter 2026	PARTNER THERAPUTICS	$60,000 income	— expenses
3rd Quarter - Report (No Activity) 3rd Quarter 2026, no activity	SEQIRUS	— income	— expenses
3rd Quarter - Termination (No Activity)replaced 3rd Quarter 2026, no activity	SEQIRUS	— income	— expenses
3rd Quarter - Report 3rd Quarter 2026	BAVARIAN NORDIC INC.	$60,000 income	— expenses
3rd Quarter - Termination (No Activity) 3rd Quarter 2026, no activity	LONGHORN	— income	— expenses
3rd Quarter - Termination (No Activity) 3rd Quarter 2026, no activity	ALVOGEN	$45,000 income	— expenses
3rd Quarter - Termination (No Activity) 3rd Quarter 2026, no activity	FRESENIUS KABI	$45,000 income	— expenses
2nd Quarter - Report 2nd Quarter 2026	FRESENIUS KABI	$45,000 income	— expenses
2nd Quarter - Report 2nd Quarter 2026	PARTNER THERAPUTICS	$60,000 income	— expenses

Clients

Everyone this filer has reported for, with the reports filed and the income they disclose.

Client	Reports	Income
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	65	$3,570,000
BAVARIAN NORDIC INC.	65	$3,035,000
GLAXOSMITHKLINE	60	$3,520,000
AMGEN, INC,	43	$2,065,000
SEQIRUS	40	$1,755,000
NOVARTIS	37	$1,650,000
ASTRAZENECA	36	$1,825,000
BAYER CORPORATION	34	$1,320,000
ALVOGEN	33	$1,470,000
PFENEX INC.	32	$1,350,000
ALERE INC.	28	$1,260,000
SMITH & NEPHEW	18	$825,000
AMAZON	16	$860,000
BIOTECHNOLOGY INDUSTRY ORGANIZATION	16	$749,000
MERCK & CO., INC.	16	$675,000
MEDIMMUNE	15	$555,000
LONGHORN	14	$770,000
RAI SERVICES COMPANY	12	$540,000
FRESENIUS MEDICAL CARE NORTH AMERICA	12	$495,000
ACHAOGEN, INC	11	$427,500
RIDGEBACK BIOTHERAPEUTICS	10	$390,000
CORBUS PHARMACEUTICALS HOLDINGS, INC	10	$385,500
ALKERMES	10	$240,000
MESO SCALE DIAGNOSTICS	9	$420,000
DAIICHI SANKYO, INC.	9	$345,000
NANOINK, INC.	9	$222,500
PAXVAX	8	$270,000
EMD SERONO, INC.	7	$200,000
EXELIXIS, INC.	6	$305,000
PARTNER THERAPUTICS	6	$300,000
GILEAD SCIENCES INC	6	$230,000
CUBIST PHARMACEUTICALS, INC.	6	$210,000
ORGANOVO	6	$160,000
FRESENIUS KABI	5	$210,000
VARIAN MEDICAL SYSTEMS, INC.	5	$195,000
ILLUMNIA, INC.	5	$137,500
PHARMATHENE, INC.	5	$75,000
EISAI, INC.	4	$120,000
INVIVYD, INC.	3	$76,000
ASTELLAS PHARMA US, INC.	3	$22,500
FOREST LABORATORIES, INC.	3	$22,500
EAST END GROUP, LLC	1	—

Lobbyists

Everyone named on this filer's reports, with the government post they most recently disclosed here.

Lobbyist	Covered position, as disclosed
KELLY CHILDRESS LANGE	Rep. Mike Rogers, Health Policy Advisor; Rep. John Shimkus, Health LA
ANDREW HAWKINS	Rep. Mike Rogers, Chief of Staff
DAVID THOMSON MOHLER	—
BARRETT THORNHILL	—
MICHAEL PAUL WOODY	Rep. Berry, LA; Sen. Harkin, LA; HELP Committee

From reports filed under the Lobbying Disclosure Act. A firm reports income from each client; an organisation lobbying for itself reports its own expenses instead. Each figure links to the filing it comes from.